insights_auto
Why is INO up ၂၄.၂၈%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၅၁ US$
arrow_upward
+၂၄.၂၈%(+၀.၂၉) 1D
၁.၅၃ US$
arrow_upward
+၁.၃၂% (+၀.၀၂၀)bedtimeAfter hours
Closed: နို ၉, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၃၀ US$
High
၁.၆၀ US$
Low
၁.၂၆ US$
Mkt. cap
၁၅.၅၅ ကုဋေ
Avg. vol.
၁.၇၄ ကုဋေ
Volume
၃.၁၁ ကုဋေ
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၇၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
Open
၁.၃၀ US$
High
၁.၆၀ US$
Low
၁.၂၆ US$
Mkt. cap
၁၅.၅၅ ကုဋေ
Avg. vol.
၁.၇၄ ကုဋေ
Volume
၃.၁၁ ကုဋေ
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၇၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
Investing.com Canada
·
ပြီးခဲ့သည့် ၉ နာရီ
Form 8K Inovio Pharmaceuticals Inc For: 9 November By Investing.com
Quantisnow
·
ပြီးခဲ့သည့် ၉ နာရီ
INO: Inovio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a...
TradingView
·
ပြီးခဲ့သည့် ၁၀ နာရီ
INO Q3'26 Earnings: EPS estimate is (0.20) USD
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc